👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Cibus director Prante Gerhard sells $4,692 in stock

Published 13/12/2024, 20:40
CBUS
-

SAN DIEGO—Prante Gerhard, a director at Cibus, Inc. (NASDAQ:CBUS), sold 1,150 shares of Class A Common Stock on December 12, 2024, according to a recent SEC filing. The transaction comes as InvestingPro analysis shows the stock trading below its Fair Value, despite experiencing significant volatility over the past year with a 72% decline. The shares were sold at an average price of $4.08, amounting to a total transaction value of $4,692. Following the sale, Gerhard retains 57,157 shares in the company. This transaction was conducted automatically under a Rule 10b5-1 trading plan, which Gerhard adopted on August 16, 2024. For deeper insights into insider trading patterns and 10+ additional ProTips about CBUS, including detailed financial health metrics, visit InvestingPro, where you'll find comprehensive Pro Research Reports covering 1,400+ US stocks.

In other recent news, Cibus Inc. has reported significant strides in its operations despite a net loss of $201.5 million. The company has announced a new base salary for executive Carlo Broos, set at $320,000, as revealed in a recent filing with the Securities and Exchange Commission. Cibus, experiencing a revenue growth of over 440% in the past year, has developed its Trait Machine process and established partnerships with major seed companies. The company anticipates earning $200 million annually in royalties from rice traits in the U.S. and an additional $150 million from expansion into Asian markets. Jefferies, however, has adjusted its price target for Cibus, reducing it to $5.00 from the previous $8.00, while maintaining a Hold rating on the stock. These recent developments reflect Cibus's ongoing efforts to enhance agricultural productivity and sustainability through gene editing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.